Didronel PMO (etidronate) is specifically licensed to treat Paget’s disease, a serious bone-thinning condition. But so enthusiastic was the manufacturer about the benefits of its drug that it urged doctors to prescribe it
These days, the first line of pharmaceutical defence against osteoporosis is a class of drugs called ‘bisphosphonates’, including risedronate and alendronate. These drugs inhibit bone resorption (wearing away of bone) and increase bone mineral...
